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Summary 
Cerebral malaria is a fatal complication of infection by Plasmodiumfakiparum  in man. The neuro- 
logical symptoms that characterize this form of malarial disease are accompanied by the adhesion 
of infected erythrocytes to the vasculature of the brain.  To study this phenomenon in vivo, an 
acute phase severe combined immunodeficiency  (SCID) mouse model was developed in which 
sequestration of P.fakiparum-infected human erythrocytes took place. During acute cerebral malaria 
in humans, the expression of intercellular adhesion molecule-1 (ICAM-1) is induced in vascular 
endothelium by inflammatory reactions. Acute phase ICAM-1 expression can also be obtained 
in SCID mice. The endothelium of the midbrain region was the most responsive to such inflam- 
matory stimulus. It is noteworthy that the reticular formation in the midbrain controls the level 
of consciousness, and loss of consciousness is a symptom of cerebral malaria.  We found that 
infected human erythrocytes  were retained 24 times more than normal erythrocytes  in ICAM-1- 
positive mouse brain. Sequestration to the brain was reduced by anti-ICAM-1 antibodies. These 
in vivo results  were confirmed by the binding of P. fakiparum-infected  erythrocytes to  the 
ICAM-l-positive endothelium in tissue sections of mouse brain.  We conclude that the SCID 
mouse serves as a versatile in vivo model that allows the study ofP.fakiparum-infected erythrocyte 
adhesion as it occurs in human cerebral malaria.  Upregulation of ICAM-1 expression in the 
region of the midbrain correlates with increased retention of malaria-infected erythrocytes and 
with the symptoms of cerebral malaria. 
p ,  lasmodium falciparum,  one of the four plasmodium spe- 
des that infect man, produces a fulminant disease that 
can lead to severe cerebral symptoms. Every year, this para- 
site causes about 250 million clinical cases of malaria (1). Ap- 
proximately 2 million individuals, mainly children under 5 
years of age, die from the main complications, which are ce- 
rebral malaria and severe anemia. A special feature of P. fal- 
ciparum pathology is the absence of mature intraerythrocytic 
stages of the parasite in the circulating blood. Mature forms 
are found attached to the lining of microvessels in peripheral 
organs. This adhesion of infected erythrocytes to the vascular 
endothelium is called sequestration. Clinically severe neuro- 
logical symptoms correlate with a much higher frequency 
of sequestered parasitized erythrocytes in the brain vascula- 
ture compared to other organs (2). 
Sequestration is thought to depend on differences  between 
P.fakiparum strains leading to the expression  of different eryth- 
rocyte surface molecules mediating adhesion to endothelia, 
as well as variation in the production of endotoxins eliciting 
a TNF-ot response by host macrophages (3). Thus, seques- 
tration depends also on the susceptibility of the host to en- 
dotoxins, the subsequent regulation of adhesion molecules, 
and the host's  level of immunity (4). A key role is played 
by TNF. Its plasma concentration levels are elevated in pa- 
tients with fatal cerebral malaria (5), and it has been shown 
that homozygotes  for the TNF2 allele, which leads to a high 
production of TNF, carry an increased risk of developing ce- 
rebral malaria (6). The inflammatory cytokine TNF regu- 
lates the expression of the adhesion molecules intercellular ad- 
hesion molecule-1 (ICAM-1), 1 vascular adhesion molecule-1 
(VCAM-1), and E- and P-selectin by vascular endothelium. 
l Abbreviations used in this  paper:. APAAP, alkaline phosphatase/anti-alkaline 
phosphatase; ICAM, intercellular adhesion molecule-I; IRBC, Plasmodiura 
fakiparum-infected human erythrocytes; rhlCAM-1, recombinant  human 
ICAM-1; rmlCAM-1, recombinant mouse ICAM-1 comtruct; SCID, severe 
combined immunodeficiency; VCAM-1, vascular cell adhesion molecule-1. 
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ciparum-infected  erythrocytes (IRBCs) (7).  The expression 
of ICAM-1 is high during inflammation and mediates adhe- 
sion of leukocytes under physiological conditions. 
The experimental study of P. falciparum  sequestration is 
hampered by the fact that the characteristic pathology de- 
velops only in humans and in squirrel monkeys (8). There- 
fore, the analysis of the interaction of the parasitized erythro- 
cytes with host endothelium is practically restricted to the 
examination of postmortem samples. Rodent malaria models 
are useful for the study of many aspects of the disease, but 
the pathology of murine plasmodium infections is different 
from that of human cerebral  malaria, and sequestration of 
parasitized erythrocytes to the brain vasculature has not been 
observed in the models used so far, except  for Plasmodium 
yoelii XL,  where infection was not associated with inflam- 
matory reactions in the brain (9,  10). An alternative is to 
investigate the  adhesion of isolated P. fakiparum-infected 
erythrocytes to cultured cell lines in vitro. The present paper 
describes  a newly developed  rodent model that allows  the 
sequestration of P. fakiparum-infected  human erythrocytes to 
the  brain  in  vivo.  It  involves  the  severe combined  im- 
munodeficient (SCID) mouse as a host for IRBC. For the 
acute phase of malaria, we present a humanized animal model 
in which the expression  of adhesion molecules by vascular 
endothelium have been induced by an inflammatory stimulus. 
It can be used for quantitative evaluation, permitting identi- 
fication of adhesion molecules involved in cerebral  malaria. 
Materials and Methods 
Reagents 
All culture  media and supplements including BSA and A1- 
buMAX  TM were obtained from Gibco Ltd. Glasgow (Paisley, Scot- 
land). The rat antimurine ICAM-1 antibodies YN 1/1.7.4 (11, 12) 
were prepared from the hybridoma cell line CRL 1878 (American 
Type Culture Collection, RockviUe, MD). The IgG fraction was 
purified  by aflfinity  chromatography  using protein G-Sepharose Fast 
4 (Pharmacia LKB, Uppsala, Sweden). Normal rat IgG was pur- 
chased from Jackson ImmunoResearch Laboratories Inc. (West 
Grove, PA). Anti-rat antibodies (Z 494) and rat alkaline phospha- 
tase/anti-alkaline phosphatase (APAAP) complex (Z 488) were ob- 
tained from Dakopatts (Glostrup, Denmark). LPS from Salmonella 
typhosa was obtained from Difco Laboratories (Detroit,  MI). 
Parasites 
The P.fakiparum strain ItG2.F6 was cultured in vitro according 
to the method of Trager and Jensen (13), but using serum-free 
medium instead. RPM11640 was supplemented  with 25 mM I-Iepes 
(BDH Laboratories  Supplies, Poole, England), 50/zg/ml hypoxan- 
thine, 0.21% (wt/vol) NaHCO3, 50/~g/ml neomycin sulfate, and 
0.5%  lipid-rich BSA (AlbuMAX  TM I) as a substrate for human 
serum (14). Erythrocytes for passages were obtained from the Swiss 
Red Cross (Berne, Switzerland). 
Mice were infected with the Plasmodium berghei ANKA  strain. 
Transfected Cells 
Murine L ceils, stably transfected with human ICAM-1, were 
a gift from Carl C. Figdor (Division of Immunology, The Nether- 
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ICAM-1 cells  were cultured in IMDM supplemented  with 1 mg/ml 
Geneticin (G-418 sulphate) and 5% FCS as described (15). Un- 
transfected control L cells were maintained without Geneticin. 
Animals 
Female  6-8-wk-old BALB/c  mice were supplied  by Charles River 
Ltd. (Sulzfeld, Germany). Female C.B-17 SCID mice were bred 
to the age of 6-12 wk under specific  pathogen-free breeding condi- 
tions at the Basel Institute for Immunology (Basel, Switzerland). 
Experimental  Infections and LPS  Treatment 
BALB/c  mice were infected by exposure to parasitized Anopheles 
steghensi mosquitoes at the facilities  of the Swiss Tropical Institute. 
These mice were held under normal breeding conditions during 
the infection and killed shortly before they died. Healthy BALB/c 
mice served as controls. SCID mice were injected intravenously 
with 10/~g LPS in 100/~1 PBS 16 h before further experiments. 
An infrared  lamp provided  additional  warmth during LPS treatment. 
Immunoenzymatic Staining Technique  for the Detection of lCAM-1 
Samples.  Frozen  tissue sections were prepared from LPS-treated 
SCID mice or control mice receiving PBS (Fig. 1), and from P. bet- 
ghei ANKA-infected  and normal BALB/c mice (Fig. 2). 
Brains were collected  immediately after death and frozen in Tis- 
sueTek (Miles Inc., Elkhart, IN). 7-/~m sections were air dried and 
fixed in acetone at room temperature for 10 min, then incubated 
for 30 min with primary antibodies YN1/1.7.4 or control rat IgG 
(10 #g/ml in PBS containing 1% BSA). All incubations were car- 
ried out at room temperature in a humid chamber and followed 
by repeated washes in PBS or TBS. After the application of the 
secondary anti-rat IgG antibodies (1:100 in TBS/1% BSA), the 
sections were incubated with the rat APAAP complex (1:50 in 
TBS/1% BSA) and exposed to the substrate solution consisting 
of 0.2 mg/ml naphthol-AS-BI-phosphate  (Fluka AG, Buchs, Swit- 
zerland), 0.4 mg/ml FastRed-TR salt (practical grade; Sigma Im- 
munochemicals, St. Louis, MO) and 0.2 rag/m1 Levamisol  (Sigma) 
in Michaelis buffer (0.14 M sodium acetate [Merck, Darmstadt, 
Germany], 0.14 M 5,5-diethyl-barbituric  acid sodium salt [Merck], 
pH 9.4). 30-40 min after color development, tissue sections were 
counterstained  with Mayer's  hematoxylin  (Fluka) and mounted with 
Mowiol (16). Antibody-labeled  tissue zones appeared red. Staining 
with normal rat IgG as the primary antibody showed a negative 
reaction. 
Quantification.  Several  microscopical  photographs in the regions 
of cerebellum, midbrain, and corpus striatum were taken. They 
were analyzed by two observers. Positively stained vessels seen in 
three randomly selected independent areas of 0.5 mm  2 per region 
were counted. 
Adhesion  of P. falciparum-infected  Human Erythrocytes 
on L  ICAM-1  Cells 
Cytoadherence  assays  were performed as previously  described  (17, 
18). Briefly, cultured IRBCs were diluted with binding medium 
(RPMI 1640, 25 mM Hepes, 0.5% Albu MAX  TM adjusted to pH 
7) to 5% hematocrit and 6-8% parasitemia. They were allowed 
to adhere for 1 h at 37~  on monolayers  ofL ICAM-1 cells, previ- 
ously cultured for 48 h on glass slides (Semadeni, Ostermundigen, 
Switzerland). The slides were gently washed 4x  with binding 
medium, air dried, fixed with methanol, stained with 5% Giemsa 
solution (Fluka) and mounted in Eukitt (Merck). Adherent IRBC 
Mouse Model for Human Cerebral Malaria were counted by light microscopy in 4-mm 2 areas of six different 
cell monolayers. 
Adhesion of P.. fakiparum-infected  Human Erythrocytes 
on Coated Soluble Molecules 
The generation of the recombinant mouse ICAM-1 construct 
(rmlCAM-1, domains 1 and 2 coupled to mouse Igt~ constant re- 
gion) is described elsewhere (19). Briefly, total RNA was isolated 
from endothelioma cells and reverse  transcribed into eDNA by stan- 
dard methods. The primers used for the amplification of the coding 
region for the extracellular domain were 5'-ATTAGAGCTCAT- 
C,  GCI3CAACCCGTC~CAAGCC-Y (5' primer) and 5'-TATACT- 
TAC~GAAAGTCCGGAGC~TCCTGGC-Y (3' primer). The 
amplified product was purified and inserted into the pHT4 vector 
containing the mouse Igg constant region as a fusion partner, cloned 
into competent Escherichia coli K803, and transfected into J558L 
myeloma cells by protoplast fusion. Supernatants were purified by 
af~nity chromatography with goat anti-mouse cK mAbs (Southern 
Biotechnology Associates, Birmingham, AL). The purified mole- 
cules were equilibrated  with PBS and frozen at -70~  The recom- 
binant  human  CD4  construct  (rhCD4)  used  as  control  is  a 
CD4-anti-CD3-cK Janusin  molecule composed of the two first 
Ig-like domains of human CD4 linked to an Fv fragment specific 
for the human CD3 molecule and coupled to mouse cK (20). This 
molecule was a kind gift from A. Trannecker  (Basel  Institute for Im- 
munology). The recombinant human ICAM-1 molecule  (rhlCAM-1) 
contains the five extracellular Ig-like domains and was a kind gift 
from J. E. Merritt (Roche Products Ltd., Welwyn Garden City, 
Hertfordshire,  England).  Drops of 15 #1 of soluble rhlCAM-1, 
rmlCAM-1,  and rhCD4 (100 #g/ml in PBS) were placed in bac- 
terial plastic petri dishes (Greiner, O. Khiner AG, Wohlen, Switzer- 
land) and incubated in a humid chamber at 4~  overnight, washed 
with PBS and blocked with 1% BSA in PBS for 30 min at room 
temperature. The petri dishes were flooded with 10 ml of cultured 
IRBCs at 5% parasitemia, diluted to 0.5% hematocrit with cul- 
ture medium. IRBCs were allowed to adhere for 1 h at 37~  in 
an atmosphere of 3% 05, 4% CO2, 93% N2. The dishes were 
gently washed with culture medium  (6 x), air dried, fixed with 
methanol,  and stained with 5% Giemsa solution (Fluka). IRBCs 
adhering to each coated area were counted by light microscopy. 
formed with brain sections from LPS-primed mice. IRBC suspen- 
sion was used at a parasitaemia of 6%. Both IRBC and brain and 
lung sections were preincubated using PBS containing  10 #g/ml 
antibody (IRBCs, 30 rain on ice; sections, 30 rain at room temper- 
ature). All other experimental conditions were as described above. 
Each experiment was carried out using five different sections. 
In  Vivo Sequestration Experiments 
Radioactively labeled mature forms of IRBCs were prepared in 
vitro. IRBC cultures of 5% hematocrit were expanded and syn- 
chronized by sorbitol treatment (22) so that cultures contained 
mainly young ring form parasites 24 h before the injection into 
mice. Subsequent labeling of parasite-containing erythrocytes with 
radioactive [3H]hypoxanthine (2 #Ci/ml culture;  Amersham In- 
ternational, Buckinghamshire, England) was carried out overnight 
during the maturation of the parasites to the late trophozoite stage 
in hypoxanthine-free culture medium. The medium of labeled cul- 
tures was exchanged several times with medium containing cold 
hypoxanthine to remove  free radioactivity.  Uninfected human RBC, 
which are normally used for IRBC culture, were labeled with StCr 
by a 30-rain incubation of packed RBCs with 300 #Ci of sodium 
chromate/ml (Amersham) of cells at 37~  The cells were washed 
with ice-cold medium and stored for 30 min at room temperature 
before the experiment. Labeled  IRBCs and RBCs were resuspended 
in  PBS at  5% hematocrit  shortly before the injection  into the 
SCID mice. 
Sequestration Experiment.  Normal and LPS-treated mice were 
injected intravenously with 200 #1 of the erythrocyte suspension. 
Labeled infected and normal human erythrocytes were allowed to 
circulate for 3 h before the mice were killed by exposure to CO2. 
The organs were excised and washed in PBS. They were lysed in 
2 ml Soluene 350 (Packard Instruments Inc., Meriden, CT) during 
12 h at 40~  and resuspended in  18 ml Picofluor (Packard) for 
~-scintillation counting of 3H incorporation, or they were counted 
as intact  organs for 3,-radiation of StCr. The organ retention of 
adherent normal RBCs and IRBCs was calculated using weight 
and radioactivity of each organ. The recovery of radioactivity in 
the dissected organs represented 42-45% 3H and 53-57% 5tCr of 
the injected dose. 
The antibody YN1/1.7.4 was administered intravenously along 
with the IRBC suspension (0.2 mg per mouse). 
Adhesion of IRBCs on Frozen Sections 
In situ binding of IRBCs was performed in analogy to a leuko- 
cyte binding assay  described  previously  (21). Freshly prepared frozen 
sections (brain and lung) of LPS-primed and control SCID mice 
were preincubated with binding medium and placed in a humid 
chamber, before IRBCs were allowed to adhere for 1 h at room 
temperature with gentle agitation.  IRBCs from suspension cul- 
ture were used at 0.1% hematocrit at a parasitemia of 10%. The 
medium was decanted from the slides and the sections were im- 
mersed in 4% paraformaldehyde (Merck) in Dulbecco's PBS which 
fixed adherent cells. They were then stained with 5% Giemsa solu- 
tion, air dried, and mounted with Eukitt for microscopic evalua- 
tion. 
Analysis of  Brain Sections.  Bound pRBCs were counted by light 
microscopy. At least four different areas of 60 fields (at a magni- 
fication of 100) were counted in the regions of  cerebellum and mid- 
brain on brain sections. 
Analysis of Lung Sections.  A minimum of 150 IRBCs were 
counted in each section. Each experiment was carried out using 
three separate sections from an organ. 
Inhibition experiments with the antibody YN1/1.7.4 were per- 
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Statistical Analysis 
Significance analysis was performed using the Student's  t test 
for two unpaired samples with equal variance. 
Results 
To study acute-phase sequestration of IRBCs in vivo, we 
developed an animal model using the SCID mouse. Since this 
mouse has a hampered immune system, it tolerates the pres- 
ence of human and malaria antigens. 
The acute phase includes the production of inflammatory 
cytokines, which in turn induce expression of adhesion mol- 
ecules by vascular endothelium of the brain that are essential 
for sequestration of circulating IRBCs. The inducible IRBC 
receptor  ICAM-1  is  an  adhesion  molecule  expressed  by 
cytokine-activated endothelial cells (23). It was found to bind 
IRBC in vitro (7). During acute-phase malaria, ICAM-1 is 
expressed by the vascular endothelium of the brain (24-27). 
In the SCID mice used as Plasmodium hosts in these experi- Figure  1.  Effect  of LPS priming on the expression of ICAM-1 in the brains of SCID mice. SCID mice were treated with LPS (10 pg/mouse) during 
16 h. Brain tissue was embedded and sagittal sections were stained with anti-ICAM-1 antibody (YN 1/1.7.4) using the APAAP technique; call structures 
were counterstained with hematoxylin.  (A) Map of sagittal section of a mouse brain. Indicated regions were of interest for analysis since they showed 
differential regulation of ICAM-1 expression. (B) Photographs  represent regions of cerebellum (a) and midbrain (b) of LPS-primed mice, as wall as 
the corresponding  regions (c and d) of normal control mice. They display longitudinal and cross-sections of several venules, whose endothdial cell 
nuclei are clearly evident. Positively stained endothelial cells appear red (x680). (C) Quantification of ICAM-1 expression in the brain of SCID mice. 
Photographs of APAAP-stained  brain sections of LPS-primed and normal SCID mice were analyzed. Positive  blood vessels in 0.5-ram 2 areas were counted. 
Three independent areas per indicated region in the brain were examined. LPS treatment induced ICAM-1 expression by endothelial cells in the region 
of midbrain and corpus striatum. ments, acute-phase ICAM-1 expression was induced by treat- 
ment with LPS. The expression of ICAM-1 was analyzed 
in different regions of the brain and compared with that of 
untreated animals. ICAM-1 expression was visualized using 
the APAAP technique. LPS treatment resulted in upregulated 
ICAM-1 expression on the endothelial  surface of small and 
large vessels in midbrain and corpus striatum (Fig. 1, B and 
C). The number of positive vessels found in the cerebellum 
was not influenced by LPS induction, but the level of expres- 
sion was increased. Normal SCID mice injected with PBS 
only, showed a small number of vessels expressing ICAM-1 
in midbrain and corpus  striatum; additionally,  the expres- 
sion level was extremely low (Fig. 1, B and C). 
Upregulation of ICAM-1 expression by brain endothelium 
of  SCID mice was further compared with that found in mice 
suffering from acute-phase murine malaria resulting from in- 
fection with P, berghei  ANKA.  The expression of ICAM-1 
in terminally ill animals was identical to that of LPS-primed 
SCID mice, suggesting that the SCID mouse can indeed be 
used as a model for the acute-stage disease (Fig. 2). In con- 
trast to human malaria, erythrocytes infected with the mu- 
rine plasmodium species do not adhere to ICAM-1 expres- 
sion vascular endothelium (9). In murine P. berghei  malaria, 
ICAM-1 expression is known to be responsible for massive 
infiltration of  leucocytes  causing a different cerebral  pathology. 
Although the P. berghei  mouse model is useful for the inves- 
tigation of other aspects of malaria disease, sequestration to 
the brain may only be studied with IRBCs. 
The organ retention of normal and P. fakiparum-infected 
human RBCs in SCID mice was determined for brain, lung, 
spleen, kidney, liver, and heart, 3 h after the injection of  labded 
infected [3H]hypoxanthine) and normal human erythrocytes 
(SlCr). The most striking difference between infected and 
normal human erythrocytes in the LPS-induced, ICAM-1- 
positive SCID mouse was found in the brain.  Retention of 
parasitized human erythrocytes was 24 times higher than that 
of uninfected ones, which indicated that there was specific 
adhesion of  infected erythrocytes to brain endothelium (Table 
1 A). In comparison to the control SCID mouse, in which 
ICAM-1 had not been induced, the number of  infected  erythro- 
cytes sequestered in the brain was significantly increased in 
the ICAM-l-positive mouse (Table 1/3). The amount of  parasi- 
tized erythrocytes sequestered to the brain, lung, and heart 
was elevated, though there were fewer in the spleen. In con- 
trast,  control mice accumulated infected erythrocytes in the 
spleen. 
The involvement of ICAM-1 in adhesion of IRBCs to the 
brain of ICAM-l-positive mice was investigated by the in- 
jection of anti-ICAM-1 antibodies along with IRBCs (Table 
2). The antibody inhibited adhesion of IRBCs in the brain 
by 34%, and this reduction was highly significant. The anti- 
body treatment had no inhibitory effect on the adhesion of 
IRBCs in other organs; IRBC retention in the lung was ac- 
tually increased in antibody-treated animals; however, this 
aspect was not further pursued.  The number of IRBCs re- 
maining in the blood circulation  of antibody treated mice 
increased by 100% compared to control animals  (Table 2 
legend). 
The determination of the adhesion of IRBC to ICAM-1 
in vitro showed that mature forms bound with high efficiency 
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Figure 2.  Effect of Plasrnodium 
berghe/-infection  on the  expression 
of ICAM-1 by  brain endothelium. 
BALB/c mice were infected with 
P. berghei  ANKA. Brain tissue of 
mice that were terminally  ill were 
embedded, and  sagittal sections 
were  incubated  with  anti- 
ICAM-1  antibody  (YN1/1.7.4) 
using  the  APAAP  technique. 
Antibody-labeled  tissue zones ap- 
pear red and other cell structures 
are counterstained with hematox- 
ylin. Photographs show a region 
of cerebellum (a) and midbrain (b) 
of  infected  mice,  and  corre- 
sponding  regions  (c  and  ~  of 
noninfected  control  mice. 
ICAM-1 expression by endothelial 
cells lining the blood vessels (ar- 
rowheM) was  strongly  induced 
after infection.  ICAM-1 was also 
expressed on activated leukocytes 
(arrou,). (x80ina, b, anddor x40 
in c). Table  1.  Frequency  of Norraal Human and IRBCs in Organs 
of SCID Mice 
Organ  IRBC  RBC  Ratio 
Table  2.  Effect of the Anti-ICAM-1  Antibody on the Retention 
of IRBCs in LPS-primed SCID Mice 
Organ  Control  YN  1/1.7.4  P 
A. 
Brain  5.8%  0.24%  24 
(415.677  _+  48.642)  (2.300  _+  720) 
Lung  7.1%  4.0%  1.8 
(507.998  _+  97.226)  (38.315  _+  9.634) 
Spleen  8.0%  10.0%  0.8 
(576.806  +  209.015)  (95.062  _+  47.348) 
Liver  71.6%  79.0%  0.9 
(5.146.360  +  777.436)  (749.263  +  47.398) 
Kidney  4.8%  5.2%  0.9 
(343.987  _+  55.790)  (49.668  +  28.884) 
Heart  2.8%  1.5%  1.9 
(201.063  _+  28.208)  (14.572  _+  4.145) 
B. 
Brain  4.6%  0.37%  12 
(308.100  _+  48.102)  (3.764  _+  1.182) 
Lung  5.4%  4.0%  1.4 
(360.865  +  88.010)  (40.867  +  11.201) 
Spleen  13.3%  6.8%  2.0 
(887.034  +  299.285)  (69.820  _+  31.108) 
Liver  69.2%  81.9%  0.8 
(4.627.482  +  583.432)  (842.906  _+  82.663) 
Kidney  4.5%  4.1%  1.1 
(303.676  _+  41.342)  (42.537  _+  17.295) 
Heart  3.0%  2.9%  1.0 
(202.879  +  42.069)  (29.699  _+  9.366) 
The retention of IRBCs (strain ItG2.F6) was compared with the reten- 
tion of normal human RBCs in LPS-primed (A) and control (B) SCID 
mice. Cultured IRBCs labeled with pH]hypoxanthine and normal hu- 
man RBCs labeled with slcr were injected intravenously into SCID 
mice. LPS (10/~g) was injected 16 h before the injection of erythrocytes. 
3 h after the injection of erythrocytes, the mice were kiUed and dissect- 
ed. The organs were washed in PBS, weighed, lysed, and the radioac- 
tivity was counted. Recovery of counts in analyzed organs was 42-45% 
for IRBCs and 53-57% for RBCs respectively. The number of counts 
for each organ was calculated using the average organ weights and disin- 
tegrations per minute per gram of tissue. The total counts of all recov- 
ered organs was taken as 100%. When compared with normal human 
RBCs, IRBC rentention in brain was increased by a factor of 24 in LPS- 
primed and by a factor of 12 in control mice. LPS priming increased the 
adhesion of IRBCs significantly in brain (P  =  0.001) and lung (P  = 
0.007), and decreased it in the spleen (P  =  0.031). n  =  8 for IRBC, 
n  m 4 for RBC per group.  Numbers in brackets represent counts per 
minute per organ. 
to murine L  cells  transfected with  human ICAM-1, while 
infected erythrocytes did not adhere to nontransfected con- 
trol L cells (data not shown).  Furthermore,  IRBC adhered 
to recombinant  mouse and human  ICAM-1 coated to the 
Brain  4.2%  2.6%  0.001 
(130.983  _+  10.374)  (86.536  -+  7.869) 
Lung  6.9%  15.9%  0.013 
(214.697  _+  34.439)  (536.394  +  113.207) 
Spleen  8.3 %  7.6 %  0.979 
(260.217  _  115.087)  (256.731  _  158.733) 
Liver  74.5%  68.1%  * 
(2.290.155  _+  281.050)  (2.302.590) 
Kidney  4.0%  3.4%  0.455 
(125.126  _+  3.317)  (115.561  +  15.719) 
Heart  2.2%  2.5%  * 
(67.581  _+  7.303)  (83.670) 
The effect of the anti-ICAM-1 antibody YN 1/1.7.4  on the retention 
of IRBC in several organs of LPS-primed SCID mice. Experimental con- 
ditions were as described in Table 1. The antibody (0.2 mg IgG per mouse) 
was injected along with IRBC. The anti-ICAM-1 antibody reduced adhe- 
sion of IRBC in the brain by 34%; the blood of these mice contained 
significantly more IRBC than control mice (YN 1/1.7.4,  906.592 _+ 
178.565 cpm/g; control, 455.308 _+  139.251 cpm/g; P  = 0.002). n = 
five per group. 
* Liver and heart were taken from one animal. Numbers in brackets 
represent counts per minute per organ. 
surface of culture dishes (Table 3).  rhCD4 and BSA served 
as control and showed marginal IR.BC binding,  i.e.,  adhe- 
sion to mouse and human ICAM-1 was significant. Human 
ICAM-1 was  three  times  more efficient in  IRBC binding 
than mouse ICAM-1. This may partially result from the com- 
position difference of the constructs;  mouse ICAM-1 con- 
tains  only the  first  two  Ig-like domains,  whereas  human 
ICAM-1 is  composed of all  five extracellular  domains. 
The interaction of IRBCs with vascular endothelium  in 
the brain was examined by an adhesion assay using frozen 
sections of normal and ICAM-l-positive SCID mice (Fig. 
3 A). The IRBCs had been allowed to adhere to the sections 
of brain and lung tissue.  Brain regions shown on the map 
of Fig. 2 A  were evaluated separately.  Infected erythrocytes 
adhering to the endothelial lining of the venules of the mid- 
brain region and the cerebellum of an ICAM-l-positive mouse 
are shown in Fig. 3 A, a and b. Note the dearly visible ma- 
ture P. fakiparum  trophozoites located in the cytoplasm of 
the erythrocytes in contact with the endothelium.  LPS in- 
duction caused a significant increase in IRBC adhesion  to 
the midbrain. The IRBC binding to cerebellum was the same 
in control and LPS-induced mice, and it correlated with the 
constitutive ICAM-1 expression found in this region of the 
brain (Fig. 3 B). Anti-ICAM-1 antibodies inhibited IRBC 
adhesion in the region of the midbrain and the cerebellum 
by 63 and 40%  respectively (Fig.  4).  The lung vasculature 
of both normal and ICAM-l-induced mice showed a high 
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Adhering  IRBC per area 
Coated molecule  (n  =  4) 
BSA  11.1  +_  1.8 
rhCD4  10.7  +  3.0 
rmlCAM-1  61.8  _+ 2.3 
rhlCAM-1  206.0  +  9.2 
rmlCAM-1, rhlCAM-1, and the controls, rhCD4 and BSA, were coated 
to plastic culture dishes as 15-/~1 drops at a concentration of 100/~g/ml 
at 4~  overnight. Cultured IRBC were allowed to adhere to the coated 
surface for I h at 37~  Subsequently,  the dishes were washed, air dried, 
and stained with Giemsa solution. Bound IRBC per coated area were 
counted by light microscopy. 
level of ICAM-1 expression (data not shown). In this tissue, 
IRBCs adhered to venules and arterioles  (Fig. 3 A, c). Binding 
efficiency to lung tissue was generally higher than binding 
to brain.  This may result from the fact that  the lung en- 
dothelium of animals kept under normal breeding conditions 
expressed ICAM-1 irrespective of induction by LPS, and the 
lungs contain more endothelial surfaces than the brain (Fig. 
3 B). 
In conclusion,  adhesion of IRBCs was more efficient in 
tissue with high ICAM-1  expression and was partially in- 
hibited by anti-ICAM-1 antibodies.  This indicates that IRBCs 
use ICAM-1 as adhesion receptors on vascular endothelium. 
Discussion 
Sequestration of infected erythrocytes is an important fea- 
ture of human acute phase malaria. In this report, we present 
a mouse model for the acute phase of malaria,  in which the 
sequestration of IRBCs in internal organs can be studied in 
vivo. This humanized mouse model allowed quantification 
of IRBC adhesion to vascular endothelium,  and we exam- 
ined the distribution of sequestered IRBC in different organs, 
including the brain. We were able to show that binding was 
related to the presence of ICAM-1 by demonstrating for the 
first time that  anti-ICAM-1  antibodies  are able to reduce 
cytoadherence of malaria-infected  erythrocytes to the microvas- 
culature of the brain.  The in vivo findings were verified by 
binding  of IRBC  to brain  tissue sections,  on which  they 
adhered predominantly  to endothelium  displaying elevated 
ICAM-1  expression. 
Upregulation  of ICAM-1  expression in the vascular en- 
dothelium  is  reported  for  human  (24),  simian  (25),  and 
murine  (26,  27)  severe malaria.  It  has  been demonstrated 
that ICAM-1 is coexpressed with CD36, thrombospondin, 
VCAM-1,  and E-selectin on the brain  microvasculature  of 
postmortem  samples of patients  who had died of cerebral 
malaria.  None of these adhesion molecules were detected in 
samples of patients who had died of other causes  (24).  A1- 
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though  their presence in the brain of malaria patients  was 
demonstrated, neither the expression level nor the precise dis- 
tribution was described. ICAM-1 expression in the brain can 
also be induced by LPS treatment. Its expression pattern was 
similar in LPS-treated animals and in terminally ill P. berghei 
-infected mice. VCAM-1 expression was also investigated and 
showed the same results (Willimann,  K., and B. A. Imhof, 
unpublished  observation).  The careful analysis  of ICAM-1 
and VCAM-1 expression in the brain of SCID mice showed 
that ICAM-1 was induced in midbrain and corpus striatum 
on the surface of small and large vessels, whereas VCAM-1 
was restricted to the macrovasculature (data not shown). This 
explained  the  10-fold higher  number  of ICAM-l-positive 
vessels as compared to VCAM-1. Since small vessels are pre- 
dominant in cerebral tissue, ICAM-1 may play a major role 
in cerebral sequestration. Furthermore, it could be speculated 
that constitutive basal expression of ICAM-1 in small vessels 
might lead to primary adhesion of a few IRBCs, which in 
turn lead to the production of ICAM-l-inducing  cytokines 
(28-30). This could result in focal clustering of large numbers 
of erythrocytes and local elevated concentrations of endotoxins 
initiating vascular pathology (31, 32). Our acute phase mouse 
model represents the final stage of such an activation cascade. 
In a study of IRBC binding to ICAM-1, it was established 
by mAb domain assignment  that a specific binding site for 
malaria-infected  erythrocytes that were repeatedly selected for 
ICAM-1 binding is located in domain 1 of human ICAM-1 
(33, 34). Molecular modeling defined a malaria binding site 
distinct  from the one for lymphocyte functional antigen-1 
(LFA-1), the physiological ligand of ICAM-1. Erythrocytes 
infected with the P.fakiparum  strain selected for strong binding 
to human ICAM-1 bound to recombinant mouse ICAM-1 
with low efficiency.  These data were obtained by static in 
vitro binding assays and may not represent physiological con- 
ditions.  In our in vivo assays, we used nonselected malaria 
strains representing a heterogeneous population. These strains 
bound to several adhesion molecules including ICAM-1, but 
with low affinity (Table 3, reference 35). Certain malaria strains 
selected for ICAM-1 binding displayed a reduced ability to 
interact with other adhesion molecules, such as CD36 (35). 
This  may suggest  that  high and low affinity binding  sites 
exist on ICAM-1.  In contrast,  another  set of experiments 
showed that IRBCs selected for their adhesion to endothelial 
cells  acquired the capacity of ICAM-1 binding  while they 
maintained the ability to bind to CD36 (36). The antibody 
YN1/1.7.4  blocked the  interaction  of mouse LFA-1  with 
mouse ICAM-1 in vitro (11, 12), and it interfered with the 
adhesion of human IRBCs in the mouse brain in vivo. This 
locates the low affinity malaria binding site close to the LFA-1 
binding  domain,  which clearly separates it from the well- 
defined high affinity binding site.  Since normal malaria in- 
fection is never caused by cloned parasites and anti-ICAM-1 
antibodies reduced the number of IRBC that were sequestered 
in the brain  in our experiments,  it is conceivable that  the 
human-mouse model represents the physiological condition 
of sequestration as a result of low affinity binding of IRBC. 
The adhesion of human malaria-infected erythrocytes to ro- 
dent  tissue  was  also  demonstrated  by Raventos-Suarez  et Figure 3.  Binding of parasitized RBC to brain and lung tissue sections of LPS-primed and normal SCID mice. 1RBC (strain ItG2.F6) from suspen- 
sion culture were allowed to adhere for 1 h at room temperature  to freshly prepared frozen sections of LPS-primed and normal SCID mice. Adhering 
cells were fixed with paraformaldehyde and stained with Giemsa solution. (A) Photographs  showing IRBCs adhering  to brain (a and b) and lung 
(c) endothelium of an LPS-primed mouse; arrowheads point to adherent  IRBCs (x720).  (B) Quantification of IRBCs adhering  to  frozen sections 
of lung and brain tissue. Two different observers counted at least four different areas of 60 fields (magnification of the microscope objective was 100) 
in the region of the cerebellum and midbrain, and a minimum  of 600 IRBCs in the lung. Each experiment was carried out in triplicate. LPS induction 
caused increased adhesion of IRBCs in the midbrain (P z  0.005). In the lung, where expression of ICAM-1 by vascular endothelium was constitutively 
high, the IRBC binding was high, irrespective of LPS treatment. 
650  Mouse Model for Human Cerebral Malaria Figure 4.  Inhibition of IRBC binding to brain tissue of LPS-primed 
SCID mice by anti-ICAM-1 antibodies. The effect  of the anti-ICAM-1 
antibody YN1/1.7.4 on the binding of IRBCs in different regions of the 
brains of LPS-primed  SCID  mice. Quantification  and experimental condi- 
tions were as described  in Fig. 3 B, but sections  and parasites were prein- 
cubated with 10/xg/ml antibody in PBS or PBS only. Each experiment 
was carried out with five  different sections. The anti-ICAM-1 antibody 
reduced adhesion of IRBC in the cerebellum  by 40% and in the midbrain 
by 63%. 
al. They studied microvascular obstruction by P. falciparum- 
infected human erythrocytes ex vivo in the isolated perfused 
rat mesocaecum (37). The addition of IRBC to the perfusate 
was shown to slow down or block in vitro blood flow, as 
a result of cytoadherence to the vascular endothelium. These 
data demonstrate that adhesion experiments performed in vivo 
or under flow conditions can provide valuable additional in- 
formation on malaria sequestration.  It was previously shown 
that anti-mouse ICAM-1 antibodies were ineffective against 
cerebral pathology (26, 27) when injected into mice bearing 
acute P. berghei  malaria.  This is not astonishing since murine 
erythrocytes infected with P. berghei  do not sequester. Their 
presence leads to cytokine release and subsequent accumula- 
tion of activated monocytes in the brain vasculature of sus- 
ceptible mice.  In the P. falciparum-SCID  mouse model,  the 
antibodies interfered specifically with the adhesion of human 
IRBC in the brain,  reducing  their  retention by one third. 
This may indicate that the expression of adhesion ligands by 
the infected red cell is plasmodium  species  specific and that 
binding to ICAM-1 is restricted to P.falciparum. Such a con- 
cept is supported by the fact that humans infected with Plas- 
modium vivax have high TNF levels in blood circulation that 
are able to induce ICAM-1 expression, but sequestration of 
infected erythrocytes has not been documented (38). The lim- 
ited number of infected erythrocytes that can be transferred 
into a SCID mouse makes it difficult to quantify in vivo se- 
questration by light microscopy. Although occasional para- 
sitized erythrocytes were seen in histological specimens, their 
number was too small to allow statistical evaluation. The use 
of  radioactively  labeled  infected  erythrocytes  facilitated 
quantification and permitted the examination of whole-organ 
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samples.  Control injection of labeled normal human erythro- 
cytes clearly distinguished  the retention  of IRBC from the 
organ  distribution  of uninfected erythrocytes in  the SCID 
mouse. Finally,  IRBC sequestration was determined by the 
ratio of parasitized  to uninfected erythrocyte retained in an 
organ.  In the acute phase mouse model,  the IRBC seques- 
tration occurred in various organs, being most pronounced 
in the brain  and most minor in lung  and heart.  Thus,  the 
pattern in the primed SCID mouse resembles the pattern re- 
ported  for human  cerebral malaria  (2,  39). 
The clinical  picture of severe malaria  disease in  humans 
reveals involvement of vital organs.  The most severe manifesta- 
tion of an organ dysfunction is found with cerebral malaria. 
Cerebral malaria begins fulminantly with a generalized con- 
vulsion followed by loss of consciousness. Further character- 
istic symptoms in comatose patients  are opisthotonus  and 
disconjugate gaze (38). So far, the precise mechanism for the 
development  of these  clinical  symptoms  remains  unclear; 
however, adhesion molecule-mediated sequestration of P.faki- 
i0arum-infected erythrocytes seems to be the main pathologic 
event. In this study, we obtained evidence for the differential 
upregulation  of ICAM-1 expression in distinct brain areas, 
suggesting a correlation  of cerebral symptoms with distur- 
bances in specific regions. If high ICAM-1 expression is taken 
as an indicator for the inflammation of the endothelium,  the 
midbrain region was shown to be most sensitive to the inflam- 
matory stimulus. LPS stimulation increased ICAM-1 expres- 
sion in the midbrain dramatically,  whereas the constitutive 
production of ICAM-1 in the endothelium of the cerebellum 
was affected minorly.  The location of the reticular  forma- 
tion, the "activating system" of the central nervous system, 
in the midbrain  region of the brainstem may have implica- 
tions for the clinical  symptoms produced. The reticular for- 
mation  controls  muscle  tone,  respiration,  blood flow,  and 
general activity of the cerebral cortex, which determines the 
level of consciousness. Pronounced reduction of the activity 
of the reticular formation is associated with unconsciousness 
(40). Furthermore,  ascending connections to the cerebellum 
are involved in the control of quite specific motor tasks such 
as the coordination of eye movement. It is therefore probable 
that  pronounced  inflammation  in  this  area,  leading  to the 
local production of toxic mediators, could cause the specific 
neurological dysfunctions observed in cerebral malaria.  Ad- 
ditionally, it is likely that impaired flow and metabolic dis- 
turbances resulting from the active metabolism of adherent, 
parasitized  cells  could also contribute to local toxicity,  en- 
hancing  the  derangement  of neuronal  function  (38). 
We conclude  that  the  SCID mouse model is a versatile 
in vivo model for the investigation of acute phase sequestra- 
tion of human malaria.  It allowed the localization of a highly 
responsive zone in the brain that reacts to the inflammatory 
stimulus caused by malaria infection.  Increased ICAM-l-medi- 
ated adhesion of IRBCs was observed in the midbrain region 
of the brainstem, a zone responsible for the level of conscious- 
ness. Thus, the humanized mouse model offers an experimental 
platform for the investigation of the molecular basis of P. j~l- 
ciparum sequestration.  Further  problems may be addressed 
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